Two-Page Introduction to AGT103-T HIV Functional Cure
AGT103-T, a potentially curative gene therapy for HIV, offers a less expensive, scalable solution compared to other cell therapies, addressing a significant unmet medical need in a multi-billion dollar market, with the potential to significantly reduce healthcare costs and new infections.
Addimmune Presentation
Addimmune, supported by a dedicated team and expert advisors, anticipates significant clinical milestones within the next two years, further advancing its mission to combat HIV.
